Sr. Director, Pharmaceutical Sciences, Business Support and New Technologies Adare Pharmaceuticals, Inc. Vandalia, Ohio
Medication acceptance and adherence has become an ever-increasing concern especially in pediatric and geriatric populations that has different pharmacokinetics and pharmacodynamics given their age and physiological, and biopharmaceutical facts. Given this deviation from standard population, design and development strategies for pediatric and geriatric dosage formulations should consider all relevant factors for successful better acceptance and adherence. This presentation discusses the differences of pediatric and geriatric population, the limitation and challenges of dosage form design and development, and strategies with focus on Adare’s platform technologies for successful patient-centric dosage forms.
Understanding the importance of patient-centric dosage forms
Challenges and limitations associated with special population, pediatric and geriatric
Strategies for development of patient-centric dosage form